CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 126 enrolled
Drug / intervention
rabeprazole+3 antibiotics +2 moredrug
Likely dose
rabeprazole+3 antibiotics 20 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02547025
NCT02547025N/ACompleted
CompareCT.gov

Personalized Treatment for Refractory H Pylori Infection

Kaohsiung Veterans General Hospital.·interventional·Posted Sep 11, 2015·Updated Oct 26, 2023

In Brief

A clinical study evaluating rabeprazole+3 antibiotics, rabeprazole+bismuth+2 antibiotics, and 1 other intervention for Helicobacter Pylori Infection. Completed, enrolled 126 participants across 1 site.

Detailed Summary

In this study, the investigators develop a personalized treatment according to culture-guided antibiotics plus high-dose proton-pump inhibitor and bismuth to treat refractory H pylori infection.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHelicobacter Pylori Infection
CountriesTaiwan
CollaboratorsKaohsiung Medical University Chung-Ho Memorial Hospital

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedSep 11, 2015
Enrollment StartAug 1, 2012
Primary CompletionOct 31, 2021
TodayJul 2, 2026
Enrollment to primary: 9.3 yearsPosted 10.8 years ago

Interventions

rabeprazole+3 antibioticsdrug

(rabeprazole 20 mg q.d.s. and three effective antibiotics) for 14 days.

rabeprazole+bismuth+2 antibioticsdrug

(rabeprazole 20 mg q.d.s., bismuth subcitrate 120 mg q.d.s. and all the effective antibiotics) for 14 days.

rabeprazole+amox+tetr+levodrug

(rabeprazole 20 mg q.d.s, amoxicillin 500 mg q.d.s., tetracycline 500 mg q.d.s. and levofloxacin 500 mg o.d.) for 14 days.